Loading the company…
Loading the company…
Families: Radiofrequency ablation (facet, genicular, basivertebral).
All companies · Product and company coverage
In the last ten years FDA made 2 decisions for Epimed International (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2024 (1). The latest was on 2024-05-24.
| Family | Decisions on record |
|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 3 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2024-05-24 | 510(k) | K232632 | Racz Neurostat RF Generator |
| 2019-03-08 | 510(k) | K190256 | Rulo Radiofrequency Lesion Probe |
| 2004-09-16 | 510(k) | K041021 | RF INTRODUCTION CANNULA |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Epimed International.
In 2025, Epimed International reported engagement with 5 surgeons and other clinicians in the states MedaRep covers, worth $1,455 in consulting, speaking, meals and travel for its device products, the most in Texas ($1,343 to 3). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Texas ($1,343, 3 engaged), Florida ($99, 1 engaged), New York ($14, 1 engaged).